Global Liposomes market is expected to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Liposomes Market Size and Outlook 2025-31

The global Liposomes market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Liposomes are spherical nano-sized bilayered vesicles or bags in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%. Infinity Market Research newest research report, the Liposomes Industry Forecast looks at past sales and reviews total world Liposomes sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposomes sales for 2025 through 2031. With Liposomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes industry. This Insight Report provides a comprehensive analysis of the global Liposomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Liposomes market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes. This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Liposomal Doxorubicin &nbsp;&nbsp;&nbsp; Liposomal Amphoteracin B &nbsp;&nbsp;&nbsp; Liposomal Paclitaxel &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Fungal Infection Therapy &nbsp;&nbsp;&nbsp; Cancer & Tumor Therapy &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Gilead Sciences &nbsp;&nbsp;&nbsp; Pacira &nbsp;&nbsp;&nbsp; Sun Pharmaceutical &nbsp;&nbsp;&nbsp; Luye Pharma &nbsp;&nbsp;&nbsp; Sigma-Tau Group &nbsp;&nbsp;&nbsp; Fudan-Zhangjiang &nbsp;&nbsp;&nbsp; Teva Pharmaceutical &nbsp;&nbsp;&nbsp; CSPC &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Kingond Pharm &nbsp;&nbsp;&nbsp; Spectrum Pharmaceuticals &nbsp;&nbsp;&nbsp; Shanghai New Asia Key Questions Addressed in this Report What is the 10-year outlook for the global Liposomes market? What factors are driving Liposomes market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Liposomes market opportunities vary by end market size? How does Liposomes break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Liposomes Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Liposomes by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Liposomes by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Liposomes Segment by Type &nbsp;2.2.1 Liposomal Doxorubicin &nbsp;2.2.2 Liposomal Amphoteracin B &nbsp;2.2.3 Liposomal Paclitaxel &nbsp;2.2.4 Others &nbsp;2.3 Liposomes Sales by Type &nbsp;2.3.1 Global Liposomes Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Liposomes Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Liposomes Sale Price by Type (2020-2025) &nbsp;2.4 Liposomes Segment by Application &nbsp;2.4.1 Fungal Infection Therapy &nbsp;2.4.2 Cancer & Tumor Therapy &nbsp;2.4.3 Others &nbsp;2.5 Liposomes Sales by Application &nbsp;2.5.1 Global Liposomes Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Liposomes Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Liposomes Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Liposomes Breakdown Data by Company &nbsp;3.1.1 Global Liposomes Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Liposomes Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Liposomes Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Liposomes Revenue by Company (2020-2025) &nbsp;3.2.2 Global Liposomes Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Liposomes Sale Price by Company &nbsp;3.4 Key Manufacturers Liposomes Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Liposomes Product Location Distribution &nbsp;3.4.2 Players Liposomes Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Liposomes by Geographic Region &nbsp;4.1 World Historic Liposomes Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Liposomes Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Liposomes Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Liposomes Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Liposomes Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Liposomes Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Liposomes Sales Growth &nbsp;4.4 APAC Liposomes Sales Growth &nbsp;4.5 Europe Liposomes Sales Growth &nbsp;4.6 Middle East & Africa Liposomes Sales Growth 5 Americas &nbsp;5.1 Americas Liposomes Sales by Country &nbsp;5.1.1 Americas Liposomes Sales by Country (2020-2025) &nbsp;5.1.2 Americas Liposomes Revenue by Country (2020-2025) &nbsp;5.2 Americas Liposomes Sales by Type (2020-2025) &nbsp;5.3 Americas Liposomes Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Liposomes Sales by Region &nbsp;6.1.1 APAC Liposomes Sales by Region (2020-2025) &nbsp;6.1.2 APAC Liposomes Revenue by Region (2020-2025) &nbsp;6.2 APAC Liposomes Sales by Type (2020-2025) &nbsp;6.3 APAC Liposomes Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Liposomes by Country &nbsp;7.1.1 Europe Liposomes Sales by Country (2020-2025) &nbsp;7.1.2 Europe Liposomes Revenue by Country (2020-2025) &nbsp;7.2 Europe Liposomes Sales by Type (2020-2025) &nbsp;7.3 Europe Liposomes Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Liposomes by Country &nbsp;8.1.1 Middle East & Africa Liposomes Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Liposomes Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Liposomes Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Liposomes Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Liposomes &nbsp;10.3 Manufacturing Process Analysis of Liposomes &nbsp;10.4 Industry Chain Structure of Liposomes 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Liposomes Distributors &nbsp;11.3 Liposomes Customer 12 World Forecast Review for Liposomes by Geographic Region &nbsp;12.1 Global Liposomes Market Size Forecast by Region &nbsp;12.1.1 Global Liposomes Forecast by Region (2026-2031) &nbsp;12.1.2 Global Liposomes Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Liposomes Forecast by Type (2026-2031) &nbsp;12.7 Global Liposomes Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Johnson & Johnson &nbsp;13.1.1 Johnson & Johnson Company Information &nbsp;13.1.2 Johnson & Johnson Liposomes Product Portfolios and Specifications &nbsp;13.1.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Johnson & Johnson Main Business Overview &nbsp;13.1.5 Johnson & Johnson Latest Developments &nbsp;13.2 Gilead Sciences &nbsp;13.2.1 Gilead Sciences Company Information &nbsp;13.2.2 Gilead Sciences Liposomes Product Portfolios and Specifications &nbsp;13.2.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Gilead Sciences Main Business Overview &nbsp;13.2.5 Gilead Sciences Latest Developments &nbsp;13.3 Pacira &nbsp;13.3.1 Pacira Company Information &nbsp;13.3.2 Pacira Liposomes Product Portfolios and Specifications &nbsp;13.3.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Pacira Main Business Overview &nbsp;13.3.5 Pacira Latest Developments &nbsp;13.4 Sun Pharmaceutical &nbsp;13.4.1 Sun Pharmaceutical Company Information &nbsp;13.4.2 Sun Pharmaceutical Liposomes Product Portfolios and Specifications &nbsp;13.4.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Sun Pharmaceutical Main Business Overview &nbsp;13.4.5 Sun Pharmaceutical Latest Developments &nbsp;13.5 Luye Pharma &nbsp;13.5.1 Luye Pharma Company Information &nbsp;13.5.2 Luye Pharma Liposomes Product Portfolios and Specifications &nbsp;13.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Luye Pharma Main Business Overview &nbsp;13.5.5 Luye Pharma Latest Developments &nbsp;13.6 Sigma-Tau Group &nbsp;13.6.1 Sigma-Tau Group Company Information &nbsp;13.6.2 Sigma-Tau Group Liposomes Product Portfolios and Specifications &nbsp;13.6.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Sigma-Tau Group Main Business Overview &nbsp;13.6.5 Sigma-Tau Group Latest Developments &nbsp;13.7 Fudan-Zhangjiang &nbsp;13.7.1 Fudan-Zhangjiang Company Information &nbsp;13.7.2 Fudan-Zhangjiang Liposomes Product Portfolios and Specifications &nbsp;13.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Fudan-Zhangjiang Main Business Overview &nbsp;13.7.5 Fudan-Zhangjiang Latest Developments &nbsp;13.8 Teva Pharmaceutical &nbsp;13.8.1 Teva Pharmaceutical Company Information &nbsp;13.8.2 Teva Pharmaceutical Liposomes Product Portfolios and Specifications &nbsp;13.8.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Teva Pharmaceutical Main Business Overview &nbsp;13.8.5 Teva Pharmaceutical Latest Developments &nbsp;13.9 CSPC &nbsp;13.9.1 CSPC Company Information &nbsp;13.9.2 CSPC Liposomes Product Portfolios and Specifications &nbsp;13.9.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 CSPC Main Business Overview &nbsp;13.9.5 CSPC Latest Developments &nbsp;13.10 Novartis &nbsp;13.10.1 Novartis Company Information &nbsp;13.10.2 Novartis Liposomes Product Portfolios and Specifications &nbsp;13.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Novartis Main Business Overview &nbsp;13.10.5 Novartis Latest Developments &nbsp;13.11 Kingond Pharm &nbsp;13.11.1 Kingond Pharm Company Information &nbsp;13.11.2 Kingond Pharm Liposomes Product Portfolios and Specifications &nbsp;13.11.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Kingond Pharm Main Business Overview &nbsp;13.11.5 Kingond Pharm Latest Developments &nbsp;13.12 Spectrum Pharmaceuticals &nbsp;13.12.1 Spectrum Pharmaceuticals Company Information &nbsp;13.12.2 Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications &nbsp;13.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Spectrum Pharmaceuticals Main Business Overview &nbsp;13.12.5 Spectrum Pharmaceuticals Latest Developments &nbsp;13.13 Shanghai New Asia &nbsp;13.13.1 Shanghai New Asia Company Information &nbsp;13.13.2 Shanghai New Asia Liposomes Product Portfolios and Specifications &nbsp;13.13.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Shanghai New Asia Main Business Overview &nbsp;13.13.5 Shanghai New Asia Latest Developments 14 Research Findings and Conclusion

Report	Global Liposomes Market Growth 2025-2031
Selected License	Single ID:LPI24148

Buyer Information

Order Summary